Market Overview

Global Systemic Psoriasis Therapeutics Market 2018-2022| Use of Combination Therapy to Spur Growth| Technavio


The global systemic psoriasis therapeutics market 2018-2022 is expected
to post a CAGR of around 10% during the forecast period, according to
the latest market research report by Technavio.

This press release features multimedia. View the full release here:

Technavio has published a new market research report on the global systemic psoriasis therapeutics m ...

Technavio has published a new market research report on the global systemic psoriasis therapeutics market from 2018-2022. (Graphic: Business Wire)

A key factor driving the growth of the market is the need for affordable
therapies. The cost of treatment mainly depends upon the type of therapy
used topical, systematic, or phototherapy. Pricing strategies are
applied like discounted price through contracts between purchases and
manufacturers, and copay coupon cards are there for most drugs. For
instance, the Celgene Patient Assistance Program provides copay cards
for OTEZLA giving patients a chance to save up to 75% off on retail cost
upon every purchase.

This market research report on the global
systemic psoriasis therapeutics market 2018-2022
also provides
an analysis of the most important trends expected to impact the market
outlook during the forecast period. Technavio classifies an emerging
trend as a major factor that has the potential to significantly impact
the market and contribute to its growth or decline.

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

In this report, Technavio highlights the use of combination therapy as
one of the key emerging trends in the global systemic psoriasis
therapeutics market:

Global systemic psoriasis therapeutics market:
Use of combination therapy

Individuals tend to develop resistance to monotherapies over a period,
resulting in the preference for combination therapies. Combination
therapies can fight psoriasis on multiple fronts due to which the total
effect is enhanced. Although biologics are very effective as a
monotherapy in treating psoriasis, a combination of topical and
traditional systemic therapies hasten the onset of action and enhance
efficiency without significant additional toxicities.

"Clinical studies, for instance, showed positive results in
combination therapy with adalimumab, infliximab, and etanercept when
taken with methotrexate in individuals with psoriasis,"
says a
senior analyst at Technavio for research on infectious and rare diseases.

Global systemic psoriasis therapeutics market:
Segmentation analysis

This market research report segments the global systemic psoriasis
therapeutics market by end-user (hospitals and retail pharmacies), by
route of administration (oral and parenteral), by product (small
molecules and biologics) and geographical regions (APAC, EMEA, and the

The Americas led the market in 2017 with a market share of close to 54%,
followed by APAC and EMEA respectively. The region is expected to
continue to dominate the market during the forecast period.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team

View Comments and Join the Discussion!